Plasma exchange for heparin-induced thrombocytopenia: is there enough evidence?
Despotis
George J
GJ
Avidan
Michael S
MS
D000906:Antibodies / Q000032:analysis; D019138:Antibodies, Blocking / Q000627:therapeutic use; D000925:Anticoagulants / Q000009:adverse effects*; D006493:Heparin / Q000009:adverse effects*; D006801:Humans; D056687:Off-Label Use; D019990:Perioperative Care; D010951:Plasma Exchange; D010956:Plasmapheresis; D010976:Platelet Count; D010978:Platelet Factor 4 / Q000037:antagonists & inhibitors / Q000276:immunology; D012701:Serotonin / Q000378:metabolism; D013917:Thrombin / Q000037:antagonists & inhibitors; D013921:Thrombocytopenia / Q000097:blood / Q000139:chemically induced* / Q000628:therapy*
D000906:Antibodies; D019138:Antibodies, Blocking; D000925:Anticoagulants; D012701:Serotonin; D010978:Platelet Factor 4; D006493:Heparin; D013917:Thrombin